Canada Pension Plan Investment Board
MLNT

Canada Pension Plan Investment Board’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40
Closed – – 1533
2020
Q1 		$0 Hold
40
– – ﹤0.01% 1548
2019
Q4 		$0 Hold
40
– – ﹤0.01% 1509
2019
Q3 		$0 Hold
40
– – ﹤0.01% 1341
2019
Q2 		$0 Hold
40
– – ﹤0.01% 1625
2019
Q1 		$0 Buy
+40
New +$217 ﹤0.01% 1673

Canada Pension Plan Investment Board's MLNT Position: Q2 2020 in Review

Canada Pension Plan Investment Board sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2020, closing a stake of 40 shares.

Canada Pension Plan Investment Board first reported a position in MLNT in Q1 2019 and held it in 5 quarters. The position peaked at $0 in Q1 2020. 0 funds tracked by Wall St. Rank hold MLNT as of Q2 2020.

  • Canada Pension Plan Investment Board reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 40 Melinta Therapeutics, Inc. Common Stock shares in Q2 2020.
  • Canada Pension Plan Investment Board first reported a position in Melinta Therapeutics, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's Melinta Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2020, filed 14 Aug 2020.